About Us
 

OPPI Members
 

Publications
 

Contact Us
 

OPPI Home Page
 

    
    
 > OPPI Vision
 > OPPI Mission
 > Office Bearers
 > Committees
 > OPPI Position on IPR
 > OPPI Position on Biosimilars
 > OPPI Position on Data Protection
 > OPPI President's Address at 41st AGM
 > 41st Annual Report
   
The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has created the first world-wide Clinical
Trials Portal
Publications
  

41st Annual Report – 2006-07
 
The Annual Report is a chronicle of various initiatives and multi-dimensional activities of the various OPPI Special Committees during the year 2006-07.

Price: (excluding Service Tax) 
Local – Indian Rupees: 350
International - U.S.$ 20

Download Free (24 Mb)
Click for more details
Order Form for Print copy
 

OPPI President’s Address at 41st AGM (September 2007)

The focus was on The Pharmaceutical Industry Poised to Reach Greater Heights. The President in his address requested the Government pragmatic approach towards Pharmaceutical Policy and ….

Price: (excluding Service Tax) 
Local – Indian Rupees: 70
International: U.S.$ 5

Download Free (13.5 Mb)
Click for more details
Order Form
 

 

OPPI – Environment, Health & Safety Guide – 2002-03

This is the Third Edition of the Guide.

Price: (excluding Service Tax) 
Local – Indian Rupees: 850
International: U.S.$ 30

Click for more details
Order Form
 

Outsourcing Opportunities in Indian Pharmaceutical Industry

The Pharmaceutical Industry in India is increasingly being recognised as a reliable source of quality medicines at affordable prices and is emerging as a global powerhouse.

Price: (excluding Service Tax)
Local – Indian Rupees: 1075
International: U.S.$ 40

Click for more details
Order Form
 


OPPI Pharmaceutical Compendium – (November 2004)

As we enter the Knowledge Economy, speedy and efficient exchange of reliable information will be a prime requirement for the efficient management of our intellectual capital.

Price: (excluding Service Tax) 
Local – Indian Rupees: 1,600
International: U.S.$ 80

Click for more details
Order Form

Corporate Social Responsibility of Pharmaceutical Companies in India: Practices, Perspectives and Way Forward

OPPI in collaboration with S.P. Jain Institute of Management & Research (SPJIMR) has completed the above Research Project to study how the Pharmaceutical Industry in India, whose primary mission is to improve the quality of life of its customers through its products and services, can leverage this strength for sustainable business growth.

Price: (excluding Service Tax)
Local: Indian Rupees 1,000
International:  U.S.$  45

Download Free (10.5 Mb)
Click for more details
Order Form


OPPI Guidelines on Good Laboratory Practices (GLP)

This document contains Guidelines for test facilities which are part of a manufacturing organisation that conduct studies (tests) which are not “regulatory studies”.

Price: (excluding Service Tax) 
Local – Indian Rupees: 120
International: U.S.$ 10

Click for more details
Order Form

OPPI Anti-Counterfeiting Guidelines

Counterfeit medicines represent an unacceptable risk to patient safety whilst at the same time jeopardizing the original manufacturer’s image, reputation and, in
extreme cases, their economic viability. It is therefore imperative that every manufacturer of prescription and OTC medicines has in place an effective operating
procedure, to make counterfeiting difficult and, to facilitate detection and investigation.

Price: (excluding Service Tax)
Local: Indian Rupees 150
International:  U.S.$  10

Download Free
Click for more details
Order Form for Print Copy